Lupin Limited has informed the Exchange regarding a press release dated March 31, 2023, titled "Lupin Receives Approval from U.S. FDA for Tenofovir Alafenamide Tablets".
Lupin Limited has informed the Exchange regarding a press release dated March 31, 2023, titled "Lupin Receives Approval from U.S. FDA for Tenofovir Alafenamide Tablets".